Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation
NCT01891578 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 23
Last updated 2013-07-03
Summary
Evaluation of immunological reconstitution after haploidentical BMT using a nonmyeloablative preparative regimen and post-transplant cyclophosphamide in patients with poor prognosis lymphoma
Conditions
Sponsors & Collaborators
-
Armando Santoro, MD
lead OTHER
Principal Investigators
-
Armando Santoro, MD · Istituto Clinico Humanitas
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia
NCT05975996 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
NCT00003954 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)
NCT00849147 ·Status: COMPLETED ·Phase: PHASE2
-
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
NCT02120157 ·Status: COMPLETED ·Phase: PHASE2
-
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
NCT02988466 ·Status: COMPLETED ·Phase: PHASE2
-
Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia
NCT06695741 ·Status: RECRUITING ·Phase: PHASE2
-
Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD
NCT01810718 ·Status: COMPLETED ·Phase: PHASE1
-
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
NCT03579875 ·Status: RECRUITING ·Phase: PHASE2
-
Two Step Haplo With Radiation Conditioning
NCT05031897 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
NCT06517641 ·Status: RECRUITING ·Phase: PHASE2
-
Auto Stem Cell Transplant for Lymphoma Patients
NCT03125642 ·Status: RECRUITING ·Phase: PHASE2
-
Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies
NCT03270748 ·Status: COMPLETED ·Phase: PHASE2
-
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma
NCT00003196 ·Status: COMPLETED ·Phase: NA
-
Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
NCT00143559 ·Status: COMPLETED ·Phase: PHASE2
-
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma
NCT02724904 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors
NCT05755854 ·Status: RECRUITING ·Phase: PHASE1
-
Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies
NCT01566656 ·Status: COMPLETED ·Phase: PHASE2
-
Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
NCT02828592 ·Status: RECRUITING ·Phase: PHASE2
-
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
NCT03314974 ·Status: RECRUITING ·Phase: PHASE2
-
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies
NCT00824135 ·Status: COMPLETED ·Phase: PHASE1
-
Experimental Bone Marrow Transplant Protocol
NCT00061581 ·Status: COMPLETED ·Phase: PHASE2
-
HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
NCT02793544 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors
NCT00186225 ·Status: COMPLETED ·Phase: NA
-
Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT00054353 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
NCT05757310 ·Status: RECRUITING ·Phase: PHASE1